Company intelligence / Profile preview

Phoenix Biotech Acquisition

Oakland, California, United States

Ownership: Private
Development stage: Other

Overview

Phoenix Biotech Acquisition was a healthcare-focused SPAC launched in 2021 to merge with or acquire companies in biotechnology and advanced therapeutics. In February 2024, it closed a business combination with CERo Therapeutics, after which Phoenix Biotech Acquisition ceased to exist as an independent public company.

Industry: Investors

Partnerships

CERo Therapeutics (business combination/merger)

Beyond the preview

Go deeper on Phoenix Biotech Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phoenix Biotech Acquisition.

Explore the full profile